Numeric Investors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Numeric Investors’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.96M	Buy	+37,460	New	+$2.77M	0.02%	535

Other funds holding MLNT

Oikos Holdings New York $422M AUM 13.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors's MLNT Position: Q4 2017 in Review

Numeric Investors opened a new position in Melinta Therapeutics, Inc. Common Stock (MLNT) in Q4 2017: 37,460 shares worth $2.96M. The stake represents 0.02% of the portfolio and ranks #535 among its holdings.

78 funds tracked by Wall St. Rank hold MLNT as of Q4 2017.

Numeric Investors held 37,460 shares of Melinta Therapeutics, Inc. Common Stock worth $2.96M as of Q4 2017.
Melinta Therapeutics, Inc. Common Stock was a new Numeric Investors position in Q4 2017.
Melinta Therapeutics, Inc. Common Stock made up 0.02% of Numeric Investors's portfolio in Q4 2017, its #535 holding.
78 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.